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SETTING THE FRAME
The term “Big Data” encompasses all the data col-
lections endowed with a sufficient “size” and lack of 
definition (having been assembled with no a priori hy-
pothesis or specific research task) to be considered as 
still largely unspoiled territories from where to derive 
new insights in the form of unforeseen regularities. In 
analogy with the exploration of the frontier lands during 
the gold rush, the exploration of such huge data reposi-
tories is usually referred to as “Data Mining”. In both 
biology and medicine literature such approaches are ex-
ponentially rising in frequency: virtually any in vitro or 
in vivo approach is complemented by an in silico section, 
where experimental results are validated by the com-
parison with results emerging from big data sets. This 
way of doing blurs the traditional concepts of “scientific 
evidence” and, at least in our opinion, is provoking a 
substantial reshaping of biomedical research.
STATE OF THE AFFAIRS 
Scientists tend to consider statistical methods as a 
largely “content independent” set of tools to be used in 
the “hypothesis testing” final phase of their work. This 
implies a neat separation of the “hypothesis generating” 
and “critical evaluation” of the experiment from the sta-
tistical testing phase. 
Typically a biologist decides to focus on some descrip-
tors (gene expression levels, protein concentrations, cell 
counts etc.) considered as instrumental for elucidating 
a given problem of interest, on the basis of his/her spe-
cific knowledge of the studied phenomenon (hypothesis 
generating phase). 
The obtained results are then collected and anal-
ysed in the context of few standard statistical frames: 
1) presence of significant correlations among a set of 
descriptors; 2) presence of a relevant effect exerted by a 
control parameter (i.e. a drug administered at different 
doses) on a variable of interest; 3) discovery of a su-
perposition between classifications of the same objects 
based on different metrics (i.e. concordance between 
genetic distances and phenotypes of a set of organisms 
or cell populations) (hypothesis testing phase).
The congruence of the results coming from hypoth-
esis testing phase with the starting hypotheses is criti-
cally evaluated in the context of existing literature (criti-
cal evaluation).
The above sketched process implies an ancillary role 
of statistical methodology that in some cases is de-
manded by a professional statistician whose role is sug-
gesting the “best way” to highlight what the “core bio-
medical team” wants to know, but the two “semantically 
relevant” parts of the study (the first and the third) do 
not really interact with the methodological issues (con-
fined in the second).
Such “classical” way of managing biomedical research 
faced a “reproducibility catastrophe” in these last ten 
years [1-3]. 
The essence of this crisis is related to “overfitting”: in 
presence of too many degrees of freedom (being they 
different variables to be analysed, different experimen-
tal conditions..) as consequence of the development 
of ‘high-throughput’ techniques allowing to measure 
thousands of different descriptors of (relatively few) in-
dependent observations, the risk of chance correlations 
becomes too high [4]. 
To face this crisis that is appearing as a fatal menace 
for knowledge advancement, one of the response was 
(roughly). “Let’s give up with contingent (and largely 
biased) theory-driven experimentations looking at this 
or that specific mechanism and look, without precon-
ceived ideas, to the “whole-thing” (the development of 
various -omics makes this possible): the emerging cor-
relations will allow for new ideas and findings spontane-
ously appear in a data-driven way”.
This is the attitude set forth by “Big Data” diffusion 
that pushes biologists to actively face the rapidly chang-
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ing way of doing science.
It is sufficiently clear that the pure enumeration of 
single relevant correlations across a huge number of 
variables only exacerbates the reproducibility crisis, 
making “pure data-driven” approaches proposed by the 
“Big Data” extremists claiming for the “end of scientific 
method”, (see for example [5] the Heaven of chance 
correlations (see [6] for a very interesting critics to the 
purely informatics approach to science). 
Other sciences, like physics and chemistry have since 
long time recognised in any scientific modelling effort, 
the simultaneous presence of “sloppy” (contingent, noisy, 
idyosincratic) and “stiff” (stable, reliable, generalizable) 
features [7]: a good piece of science must discriminate 
between “stiff” and “sloppy” part of information.
How this discrimination is possible when facing “Big 
Data” in biology, where we cannot rely (like happens 
in physics and chemistry) on reliable quantitative the-
ories that allow a strict a priori filtering of incoming 
information?
SENSIBLE USE OF BIG DATA EXPLORATIVE 
APPROACHES
The scientist does not know in advance if a given 
variable will be of use for his/her goal or not, thus it is 
a good rule to consider more observables than neces-
sary (this is why “Big Data” are potentially very useful 
in biomedical sciences), leaving the subsequent steps 
of the analysis to “keep alive” only the relevant part of 
information. 
Jean Paul Guigou [8] has aptly defined the multidi-
mensional methods as those that allow the simultane-
ous treatment of variables “which are numerous, ap-
proximate, not very significant (in the sense that each 
of them, singly, carries limited information), discrete 
or continuous, heterogeneous, qualitative or quanti-
tative”. This is exactly the situation of a data mining 
enterprise: the plethora of “approximate, not very sig-
nificant” pieces of information must collapse into few 
relevant “coarse grain” integrated descriptors emerging 
as “meaningful summaries” that keep only the “corre-
lated part of information”, i.e. the consensus among 
many different descriptors condensed into global scores 
(principal component analysis is the by far most com-
mon tool to obtain this goal, and stands as a perfect 
example of systemic attitude since more than one cen-
tury [9]).
This implies “the whole” is not an unstructured collec-
tion of pieces of information but an organized system of 
relations among variables. This systemic view asks for a 
direct engagement of biologists (experts-in-the-field ac-
cording to data science jargon) into statistical analysis.
The distillation of shared (and thus robust) informa-
tion initially dispersed into a plethora of descriptors can 
by no means intended as a pure statistical procedure 
devoid of any link with the specific biological question. 
On the contrary, the progressive emerging of a relation 
structure from the raw data set corresponds to what 
we called “hypothesis generating” phase and asks for 
a “critical evaluation” by the biologist that must criti-
cally follow the entire data analysis procedure that is 
no more a largely ancillary (and thus prone to be del-
egated) hypothesis testing procedure but the actual 
scientific work. The conflation of the three classically 
distinct phases of “hypothesis generating”, “hypothesis 
testing” and “critical evaluation” into a single organic 
activity asks for a reshaping of the scientific culture and 
education toward a recovery of the “generalist” scientist 
(that is practically extinct since more than fifty years). 
The end of over-specialization could be the “sun” shin-
ing at the end of the information crisis tunnel.
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